AU4346089A - Compositions containing cyclosporins - Google Patents

Compositions containing cyclosporins

Info

Publication number
AU4346089A
AU4346089A AU43460/89A AU4346089A AU4346089A AU 4346089 A AU4346089 A AU 4346089A AU 43460/89 A AU43460/89 A AU 43460/89A AU 4346089 A AU4346089 A AU 4346089A AU 4346089 A AU4346089 A AU 4346089A
Authority
AU
Australia
Prior art keywords
compositions containing
containing cyclosporins
cyclosporins
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43460/89A
Inventor
Rajan Madhok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4346089A publication Critical patent/AU4346089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU43460/89A 1988-10-07 1989-10-06 Compositions containing cyclosporins Abandoned AU4346089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8823621 1988-10-07
GB888823621A GB8823621D0 (en) 1988-10-07 1988-10-07 Compositions containing cyclosporins

Publications (1)

Publication Number Publication Date
AU4346089A true AU4346089A (en) 1990-05-01

Family

ID=10644893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43460/89A Abandoned AU4346089A (en) 1988-10-07 1989-10-06 Compositions containing cyclosporins

Country Status (3)

Country Link
AU (1) AU4346089A (en)
GB (1) GB8823621D0 (en)
WO (1) WO1990003793A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659460B2 (en) * 1991-06-27 1995-05-18 Novartis Ag Improvements in or relating to organic compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679119A5 (en) * 1988-05-13 1991-12-31 Sandoz Ag
SK277092A3 (en) * 1992-09-07 1996-08-07 Galena As Medicaments with n-methylated cyclic undecapeptides
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
JPH09194375A (en) * 1996-01-17 1997-07-29 Senju Pharmaceut Co Ltd Immunosuppressive effect potentiating agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006463A1 (en) * 1986-05-02 1987-11-05 Brigham And Women's Hospital A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659460B2 (en) * 1991-06-27 1995-05-18 Novartis Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
WO1990003793A1 (en) 1990-04-19
GB8823621D0 (en) 1988-11-16

Similar Documents

Publication Publication Date Title
AU2885389A (en) Cyclosporin compositions
GB2222770B (en) Pharmaceutical compositions containing cyclosporins
AU4148789A (en) Novel hydrogen phosphonodithioate compositions
AU4290789A (en) Oral compositions
AU3481089A (en) Oral compositions
AU3588089A (en) Oral compositions
AU4148989A (en) Pharmaceutical compositions
AU4022789A (en) Detergent compositions
AU2373188A (en) Sunscreen compositions
AU3674489A (en) Pharmaceutical compositions
AU3480889A (en) Oral compositions
AU3634589A (en) Improved primer compositions
AU3785489A (en) Perfumery compositions
AU3398989A (en) Detergent compositions
AU626930B2 (en) Immunostimulatory composition
AU3310789A (en) Macrolide compositions
AU2891589A (en) Polymeric compositions
AU3015189A (en) Cleansing compositions
AU4108089A (en) Detergent compositions
AU4371589A (en) Cyclosporin opthalmic compositions
AU3946689A (en) Oral compositions
AU4447189A (en) Oral compositions
AU4107889A (en) Detergent compositions
AU4293989A (en) Bleaching compositions
AU4107989A (en) Detergent compositions